CSF2, colony stimulating factor 2, 1437

N. diseases: 1028; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.320 Biomarker disease BEFREE In the present study, we evaluated the effects of an Ad-p53/GM-CSF/B7-1-modified myeloma cell vaccine strategy aimed to induce apoptosis and to augment the immunogenicity of MM cells. 16001164 2006
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.320 Therapeutic disease CTD_human In this study, the kinetics of mobilization of normal hematopoietic stem cells were compared with those of myeloma cells present in PBSC harvests of 12 patients after high-dose cyclophosphamide and granulocyte-macrophage colony-stimulating factor administration. 8555506 1996
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.320 Therapeutic disease CTD_human Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single-dose cyclophosphamide combined with rhGM-CSF or rhG-CSF. 7540856 1995
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.320 Biomarker disease BEFREE Cytogenetic studies were performed on BM cells after longterm cultures (6 days) with stimulation of cultures by granulocyte-macrophage colony-stimulating factor (GM-CSF), GM-CSF plus interleukin (IL)-6, IL-3 plus IL-6, or GM-CSF plus IL-3 plus IL-6 to improve myeloma cell growth, and 91 patients had an additional unstimulated culture. 7537117 1995
CUI: C0026764
Disease: Multiple Myeloma
Multiple Myeloma
0.320 Therapeutic disease CTD_human Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). 8104070 1993